PFBT
BIIB icon

Parkside Financial Bank & Trust’s Biogen BIIB Stock Holding History

Parkside Financial Bank & Trust’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$340K Buy
1,855
+84
+5% +$15.5K 0.03% 326
2025
Q4 		$312K Buy
1,771
+32
+2% +$5.23K 0.02% 350
2025
Q3 		$244K Buy
1,739
+92
+6% +$12.4K 0.02% 392
2025
Q2 		$207K Buy
1,647
+216
+15% +$26.9K 0.02% 420
2025
Q1 		$196K Buy
1,431
+23
+2% +$3.29K 0.02% 392
2024
Q4 		$215K Sell
1,408
-104
-7% -$17.5K 0.03% 364
2024
Q3 		$293K Sell
1,512
-57
-4% -$11.9K 0.04% 289
2024
Q2 		$364K Buy
1,569
+18
+1% +$3.91K 0.06% 238
2024
Q1 		$334K Sell
1,551
-6
-0.4% -$1.41K 0.05% 256
2023
Q4 		$403K Buy
1,557
+22
+1% +$5.4K 0.07% 202
2023
Q3 		$395K Buy
1,535
+14
+0.9% +$3.75K 0.09% 165
2023
Q2 		$433K Buy
1,521
+17
+1% +$5.06K 0.1% 154
2023
Q1 		$418K Buy
1,504
+95
+7% +$26.3K 0.11% 141
2022
Q4 		$390K Buy
1,409
+16
+1% +$4.52K 0.11% 150
2022
Q3 		$372K Sell
1,393
-22
-2% -$4.67K 0.12% 142
2022
Q2 		$289K Sell
1,415
-61
-4% -$12.5K 0.09% 171
2022
Q1 		$311K Buy
1,476
+73
+5% +$15.9K 0.08% 172
2021
Q4 		$337K Buy
1,403
+3
+0.2% +$771 0.08% 171
2021
Q3 		$397K Sell
1,400
-15
-1% -$4.92K 0.12% 124
2021
Q2 		$490K Buy
1,415
+12
+0.9% +$3.63K 0.14% 110
2021
Q1 		$393K Sell
1,403
-6
-0.4% -$1.62K 0.12% 130
2020
Q4 		$345K Buy
1,409
+13
+0.9% +$3.35K 0.11% 137
2020
Q3 		$396K Sell
1,396
-11
-0.8% -$3.07K 0.14% 104
2020
Q2 		$376K Sell
1,407
-28
-2% -$8.42K 0.12% 120
2020
Q1 		$454K Buy
1,435
+31
+2% +$9.41K 0.17% 79
2019
Q4 		$416K Buy
1,404
+15
+1% +$4.16K 0.12% 126
2019
Q3 		$324K Sell
1,389
-9
-0.6% -$2.1K 0.1% 142
2019
Q2 		$327K Buy
1,398
+73
+6% +$16.9K 0.11% 144
2019
Q1 		$313K Sell
1,325
-73
-5% -$23K 0.11% 148
2018
Q4 		$420K Buy
1,398
+21
+2% +$6.7K 0.15% 97
2018
Q3 		$486K Buy
1,377
+16
+1% +$5.51K 0.17% 99
2018
Q2 		$395K Sell
1,361
-91
-6% -$25.6K 0.15% 115
2018
Q1 		$397K Sell
1,452
-108
-7% -$33.5K 0.15% 104
2017
Q4 		$497K Buy
1,560
+120
+8% +$38.5K 0.18% 91
2017
Q3 		$451K Buy
1,440
+1,345
+1,416% +$398K 0.18% 92
2017
Q2 		$25K Buy
95
+29
+44% +$7.67K 0.01% 478
2017
Q1 		$18K Sell
66
-480
-88% -$136K 0.01% 548
2016
Q4 		$155K Sell
546
-4
-0.7% -$1.19K 0.07% 175
2016
Q3 		$172K Buy
550
+1
+0.2% +$296 0.08% 169
2016
Q2 		$133K Sell
549
-32
-6% -$8.43K 0.06% 186
2016
Q1 		$151K Buy
581
+29
+5% +$7.66K 0.08% 172
2015
Q4 		$169K Buy
552
+21
+4% +$6.03K 0.08% 153
2015
Q3 		$155K Sell
531
-174
-25% -$57.5K 0.09% 153
2015
Q2 		$284K Sell
705
-15
-2% -$6.02K 0.15% 126
2015
Q1 		$304K Buy
720
+48
+7% +$18.9K 0.16% 124
2014
Q4 		$229K Buy
672
+42
+7% +$13.6K 0.13% 148
2014
Q3 		$209K Buy
+630
New +$208K 0.13% 157

Other funds holding BIIB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Parkside Financial Bank & Trust's BIIB Position: Q1 2026 in Review

Parkside Financial Bank & Trust increased its Biogen (BIIB) stake by 4.7% in Q1 2026, buying an estimated $15.5K and bringing the position to 1,855 shares worth $340K. The position accounts for 0.03% of the portfolio, ranked #326.

Parkside Financial Bank & Trust first reported a position in BIIB in Q3 2014 and has held it in 47 quarters since. The position peaked at $497K in Q4 2017. 1,006 funds tracked by Wall St. Rank hold BIIB as of Q1 2026.

  • Parkside Financial Bank & Trust held 1,855 shares of Biogen worth $340K as of Q1 2026.
  • Parkside Financial Bank & Trust bought 84 Biogen shares in Q1 2026, an estimated $15.5K.
  • Biogen made up 0.03% of Parkside Financial Bank & Trust's portfolio in Q1 2026, its #326 holding.
  • Parkside Financial Bank & Trust first reported a position in Biogen in Q3 2014 and has held it in 47 quarters since.
  • Parkside Financial Bank & Trust's Biogen position peaked at $497K in Q4 2017.
  • 1,006 funds tracked by Wall St. Rank held Biogen as of Q1 2026.

Based on Parkside Financial Bank & Trust's 13F filing for Q1 2026, filed 13 May 2026.